Search Results - "Journal of clinical rheumatology"

Refine Results
  1. 1

    The Visual Analogue Scale Versus Numerical Rating Scale in Measuring Pain Severity and Predicting Disability in Low Back Pain by Shafshak, Tarek Saad, Elnemr, Rehab

    Published in Journal of clinical rheumatology (01-10-2021)
    “…BACKGROUNDLow back pain (LBP) is a public health problem that requires accurate assessment for proper management and predicting prognosis. OBJECTIVEThis study…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Autoantibodies in Patients With Immune-Related Adverse Events From Checkpoint Inhibitors: A Systematic Literature Review by Ghosh, Nilasha, Chan, Karmela K., Jivanelli, Bridget, Bass, Anne R.

    Published in Journal of clinical rheumatology (01-03-2022)
    “…Immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs) are sometimes associated with autoantibodies, but we do not know how frequently…”
    Get full text
    Journal Article
  4. 4

    Patient Burden of Axial Spondyloarthritis by Strand, Vibeke, Singh, Jasvinder A

    Published in Journal of clinical rheumatology (01-10-2017)
    “…Axial spondyloarthritis (AxSpA) is an inflammatory spondyloarthritis (SpA) that has significant impact on a patient's life. Symptoms, including fatigue, sleep…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Checkpoint Inhibitor–Associated Arthritis: A Systematic Review of Case Reports and Case Series by Ghosh, Nilasha, Tiongson, Michael D., Stewart, Carolyn, Chan, Karmela K., Jivanelli, Bridget, Cappelli, Laura, Bass, Anne R.

    Published in Journal of clinical rheumatology (01-12-2021)
    “…OBJECTIVEWe performed a systematic literature review to identify all reports of immune checkpoint inhibitor–associated inflammatory arthritis to describe it…”
    Get full text
    Journal Article
  7. 7

    Sympathetic Nervous System Dysfunction in Fibromyalgia, Chronic Fatigue Syndrome, Irritable Bowel Syndrome, and Interstitial Cystitis: A Review of Case-Control Studies by Martínez-Martínez, Laura-Aline, Mora, Tania, Vargas, Angélica, Fuentes-Iniestra, Mario, Martínez-Lavín, Manuel

    Published in Journal of clinical rheumatology (01-04-2014)
    “…BACKGROUNDFibromyalgia often coexists and overlaps with other syndromes such as chronic fatigue, irritable bowel syndrome, and interstitial cystitis. Chronic…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Clinical Manifestations and Diagnosis of Axial Spondyloarthritis by Walsh, Jessica A., Magrey, Marina

    Published in Journal of clinical rheumatology (01-12-2021)
    “…BACKGROUNDAxial spondyloarthritis (axSpA) is a chronic, rheumatic disease characterized by inflammation of the sacroiliac joint, spine, and entheses. Axial…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Mobile Apps for Individuals With Rheumatoid Arthritis: A Systematic Review by Luo, Dee, Wang, Penny, Lu, Fengxin, Elias, Josephine, Sparks, Jeffrey A., Lee, Yvonne C.

    Published in Journal of clinical rheumatology (01-04-2019)
    “…BACKGROUNDMobile health applications (apps) have the potential to help individuals with chronic illnesses learn about, monitor, and manage their condition, but…”
    Get full text
    Journal Article
  13. 13

    Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis by Yip, Ronald Man Lung, Yim, Cheuk Wan

    Published in Journal of clinical rheumatology (01-12-2021)
    “…ABSTRACTRheumatoid arthritis (RA) is a multisystem disease that affects the joints and various organs, resulting in compromised quality of life and increased…”
    Get full text
    Journal Article
  14. 14

    The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis by Alves, Carlos, Penedones, Ana, Mendes, Diogo, Marques, Francisco Batel

    Published in Journal of clinical rheumatology (01-03-2022)
    “…The Janus kinases (JAKs) are cytoplasmic tyrosine kinases associated with membrane cytokine receptors that mediate signaling of multiple cytokines and growth…”
    Get full text
    Journal Article
  15. 15

    International Perspectives on Joint Hypermobility: A Synthesis of Current Science to Guide Clinical and Research Directions by Nicholson, Leslie L., Simmonds, Jane, Pacey, Verity, De Wandele, Inge, Rombaut, Lies, Williams, Cylie M., Chan, Cliffton

    Published in Journal of clinical rheumatology (01-09-2022)
    “…There is exponential clinical and research interest in joint hypermobility due to recognition of the complexity of identification, assessment, and its…”
    Get full text
    Journal Article
  16. 16

    VEXAS Syndrome—A Review of Pathophysiology, Presentation, and Prognosis by Koster, Matthew J., Samec, Matthew J., Warrington, Kenneth J.

    Published in Journal of clinical rheumatology (01-09-2023)
    “…Abstract VEXAS ( V acuoles, E 1 enzyme, X -linked, A utoinflammatory, S omatic) syndrome is a newly identified disease caused by somatic mutations in the UBA1…”
    Get full text
    Journal Article
  17. 17

    Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019 by Murayama, Anju, Mamada, Hanano, Shigeta, Haruki, Yoshinaga, Takamichi, Saito, Hiroaki, Yamashita, Erika, Tanimoto, Tetsuya, Ozaki, Akihiko

    Published in Journal of clinical rheumatology (01-04-2023)
    “…Given the increasing number of novel and expensive drugs for rheumatoid diseases, the financial relationships between pharmaceutical companies and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Risk of Toxicity After Initiating Immune Checkpoint Inhibitor Treatment in Patients With Rheumatoid Arthritis by Efuni, Elizaveta, Cytryn, Samuel, Boland, Patrick, Niewold, Timothy B., Pavlick, Anna, Weber, Jeffrey, Sandigursky, Sabina

    Published in Journal of clinical rheumatology (01-10-2021)
    “…INTRODUCTIONImmune checkpoint inhibitors (ICIs) are increasingly used to treat advanced cancer. Rheumatoid arthritis (RA) is associated with an increased risk…”
    Get full text
    Journal Article
  20. 20

    Real-World Experience of Tixagevimab and Cilgavimab (Evusheld) in Rheumatologic Patients on Rituximab by Ocon, Anthony J., Mustafa, S. Shahzad

    Published in Journal of clinical rheumatology (01-03-2023)
    “…Although vaccination is the primary strategy against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), rheumatologic patients on B-cell depleting…”
    Get full text
    Journal Article